Evidence map›Paper›PMID 38358883›Full record

ArticleCell reports2024

Harnessing noncanonical crRNAs to improve functionality of Cas12a orthologs.

Long T Nguyen, Nicolas C Macaluso, Noah R Rakestraw, Dylan R Carman, Brianna L M Pizzano, Raymond C Hautamaki, Santosh R Rananaware, Isabel E Roberts, Piyush K Jain

Abstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Architecture of a DNA-guided Cas12a.Nature structural & molecular biology · 2026
    Article
  2. Article
  3. Molecular mechanisms and biotechnology applications of CRISPR-Cas12a.Nature reviews. Molecular cell biology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. AsCas12a tolerates insertions in target DNA.Nucleic acids research · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Long T NguyenDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.
Nicolas C MacalusoDepartment of Chemical and Biomolecular Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, USA.
Noah R RakestrawDepartment of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA.
Dylan R CarmanDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.
Brianna L M PizzanoDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.
Raymond C HautamakiDepartment of Microbiology and Cell Science, College of Agricultural and Life Sciences, University of Florida, Gainesville, FL, USA.
Santosh R RananawareDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.
Isabel E RobertsDepartment of Chemical Engineering, John and Marcia Price College of Engineering, University of Utah, Salt Lake City, UT, USA.
Piyush K JainDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA; Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA; Health Cancer Center, University of Florida, Gainesville, FL, USA. Electronic address: jainp@ufl.edu.

Funding

Discovery and engineering of CRISPR/Cas systemsR35GM147788 · NIGMS · UNIVERSITY OF FLORIDA · PI Piyush K Jain · 2022 to 2026
$1.8M
Rapid point-of-care detection of Hepatitis C viral RNA using multiplexed CRISPR/Cas platformsR21AI168795 · NIAID · UNIVERSITY OF FLORIDA · PI JAIN, PIYUSH K · 2022 to 2023
$419k
NIAID NIH HHS R21 AI168795NIGMS NIH HHS R35 GM147788
6 · The paper itself

Abstract

There is a broad diversity among Cas12a endonucleases that possess nucleic acid detection and gene-editing capabilities, but few are studied extensively. Here, we present an exhaustive investigation of 23 Cas12a orthologs, with a focus on their cis- and trans-cleavage activities in combination with noncanonical crRNAs. Through biochemical assays, we observe that some noncanonical crRNA:Cas12a effector complexes outperform their corresponding wild-type crRNA:Cas12a. Cas12a can recruit crRNA with modifications such as loop extensions and split scaffolds. Moreover, the tolerance of Cas12a to noncanonical crRNA is also observed in mammalian cells through the formation of indels. We apply the adaptability of Cas12a:crRNA complexes to detect SARS-CoV-2 in clinical nasopharyngeal swabs, saliva samples, and tracheal aspirates. Our findings further expand the toolbox for next-generation CRISPR-based diagnostics and gene editing.

Indexed as

CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsAnimalsEndonucleasesGene EditingMammalsSARS-CoV-2EndonucleasesRNA, Guide, CRISPR-Cas SystemsCas12a orthologscCRISPRclinical diagnosticscombinatorial CRISPR-CasCP: Molecular biologyCRISPR-CasCRISPR-Cas12agene editingnon-canonical crRNAnucleic acid detectionSARS-CoV-2

Identifiers

PMID38358883
PMCPMC11031708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.